Stock Market Reviews

ACB (Aurora Cannabis Inc.) News

Get the latest news, insights, and market updates on ACB (Aurora Cannabis Inc.). Explore the news page 5 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Cannabis stocks climb as Trump weighs marijuana rescheduling
  Investing.com -- Cannabis stocks surged Friday after reports that President Donald Trump is considering directing his administration to reclassify marijuana as a less dangerous drug, potentially marking a significant shift in U.S. policy.
  Dec 12, 2025 - $ACB
• Trump Lights Up the Cannabis Market With Plans for Reclassification
  The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like heroin and LSD — cannabis is deemed to have no accepted medical use and high abuse potential. This status blocks research, interstate commerce, ... Trump Lights Up the Cannabis Market With Plans for Reclassification
  Dec 12, 2025 - $ACB
• Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland
  Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Black Jelly, a proprietary cultivar, in Poland, expanding the company's portfolio of high-potency medical cannabis products in one of Europe's fastest-growing markets. Grown and manufactured in Aurora's Canadian GACP and EU-GMP certified facilities, Black Jelly joins Farm Gas and Sourdough under the Cannabis flos Aurora brand portfolio.
  Dec 11, 2025 - $ACB
• Cronos Group Plans Strategic Europe Expansion: How to Play the Stock?
  CRON's planned CanAdelaar acquisition boosts its push into the Dutch adult-use cannabis market and highlights its strengthening international momentum.
  Dec 10, 2025 - $ACB
• Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  Key Takeaways; Cannabis Sector Curaleaf Plans to Move into Virginia with $110 Million Acquisition of Competitor’s Assets Aurora Expanded Australian Footprint Through a New Distribution Deal MediPharm Labs Entered French Market with First Cannabis Shipment High Tide Launched First European Canna Cabana in Berlin Key Takeaways; Psychedelic Sector NRx Pharmaceuticals Advanced Preservative-Free Ketamine and Expanded […]
  Dec 8, 2025 - $ACB
• Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand
  Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces Kerry Miller, a 35-year consumer packaged goods executive, as Managing Director for Australia and New Zealand, effective January 15, 2026. Kerry will be instrumental in driving growth in these key markets, drawing on decades of global experience in fast moving, regulated industries.
  Dec 8, 2025 - $ACB
• Rigetti Computing Stock Plunged 42% Last Month. Here's Why.
  Rigetti's November plunge erased October's gains and then some. Is the quantum computing stock a buy in this sudden dip?
  Dec 4, 2025 - $ACB
• Aurora Announces Distribution Partnership with Leafio Australia
  Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announced the company's wholly owned subsidiary, MedReleaf Australia, has entered into a distribution partnership with Leafio, the wholesale distribution arm of Montu Australia. This strategic partnership will expand patient access to trusted, safe, and effective medical cannabis across Australia, while supporting healthcare professionals with educational resources. Leafio will serve
  Dec 2, 2025 - $ACB
• Rubicon Organics Announces Appointment of Glen Ibbott as CFO
  VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX: ACB, Nasdaq: ACB) as its Chief Financial Officer and Corporate Secretary. “Over the past si
  Nov 13, 2025 - $ACB
• Aurora Cannabis: Medical Sales Boom Worldwide, Cash Flow to Swing Positive – Quarterly Update Report
  Download the Complete Report Here By Brandon Hornback Aurora Cannabis Inc. (NASDAQ: ACB) smoked another quarter, led by top-line growth, profitability, and disciplined capital allocation. And in fresh news, there’s positive cash flow right around the corner. Take a hit off this: The top line increased 11%, driven primarily by strong medical cannabis performance linked […]
  Nov 10, 2025 - $ACB